TAK003 dengue vaccine: A promising tool for dengue control

Nitika Nitika; Praveen K Bharti

doi:10.4103/apjtm.apjtm_571_24

Asian Pacific Journal of Tropical Medicine ›› 2024, Vol. 17 ›› Issue (11) :477 -478. DOI: 10.4103/apjtm.apjtm_571_24

Perspective

research-article

TAK003 dengue vaccine: A promising tool for dengue control

Nitika Nitika ¹^,²
, Praveen K Bharti ¹^,²

Author information +

History +

PDF (173KB)

Cite this article

Download citation ▾

Nitika Nitika, Praveen K Bharti. TAK003 dengue vaccine: A promising tool for dengue control. Asian Pacific Journal of Tropical Medicine, 2024, 17 (11) : 477-478 DOI:10.4103/apjtm.apjtm_571_24

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Friedrich MJ. WHO’s top health threats for 2019. JAMA 2019; 321(11): 1041.

[2]	Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: An analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 2016; 16(6): 712-723.

[3]	Sahu MC, Samantaray RK, Pal A, Pati S. Recent advances on pathogenesis, diagnosis, prevention, immunological aspects, and vectors of dengue: A review. Asian Pac J Trop Biomed 2023; 13(8): 325-338.

[4]	Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, et al. The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): A model comparison study. PLoS Med 2016; 13(11): e1002181.

[5]	López-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, Bravo L, Sirivichayakul C, et al. Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents 2 years after vaccination. J Infect Dis 2022; 225(9): 1521-1532.